Rhythm Pharmaceuticals, Inc. RYTM Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s intangibles (net)?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported intangibles (net) of $5.11M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s intangibles (net) decreased by 14.3% year-over-year, from $5.96M to $5.11M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s intangibles (net)?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s intangibles (net) has grown at a 3.4% compound annual growth rate (CAGR), from $4.66M to $5.32M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.